DRG economics and cost-per-case profitability analysis

Building the cost-per-case model

To know if a case earns or loses money, you compare the fixed payment against what it actually cost you to deliver. Cost per case breaks into a few big buckets.

The cost buckets

1. Length of stay (LOS) costs. Every day a patient occupies a bed carries a "per diem" cost: nursing, room, meals, monitoring, basic pharmacy. This is often the single largest variable. A patient who stays 6 days instead of 3 roughly doubles this bucket.

2. Supply and implant costs. The physical items used: implants, devices, drugs, disposables. In orthopedics and cardiology, a single implant can cost several thousand dollars and dominate the case.

3. Procedure and OR time. Operating room minutes are expensive because they consume staff, equipment, and anesthesia. A procedure that runs long burns margin fast.

4. Ancillary services. Imaging, labs, physical therapy. Individually small, collectively meaningful.

A worked example

Let us model two knee replacement patients paid under the same DRG. Assume a fixed DRG payment of $16,000 for both (illustrative numbers, not a quoted rate).

| Cost item | Patient A | Patient B |

|---|---|---|

| Implant | $5,000 | $5,000 |

| OR time | $3,500 | $3,500 |

| Room per diem | $1,800/day x 2 = $3,600 | $1,800/day x 5 = $9,000 |

| Ancillaries | $1,200 | $2,500 |

| Total cost | $13,300 | $20,000 |

| Payment | $16,000 | $16,000 |

| Margin | +$2,700 | -$4,000 |

Same procedure. Same payment. One earns money, one loses money. The only difference is length of stay and a few extra ancillaries.

This is why hospitals obsess over LOS. Every avoidable day pushes a profitable case toward a loss.

Length of stay is the swing factor

Notice how the per diem line moved the result. LOS is usually the biggest lever a hospital can actually control, because implant prices and DRG payments are largely set by contracts and regulation.

This is the logic behind discharge planning, case management, and "care pathways" (standardized step-by-step plans for a given condition). Getting a patient safely home one day sooner is not just clinically good. It converts a losing case into a winning one.

There is a limit. Discharging too early risks readmission. Medicare's Hospital Readmissions Reduction Program penalizes hospitals with excess readmissions for certain conditions. So the goal is not the shortest stay. It is the right stay: fast enough to protect margin, safe enough to avoid a penalty.

Supply costs and the implant problem

In some service lines, the implant is the story. Spine surgery, joint replacement, and cardiac rhythm devices can carry supply costs so high that the payment barely covers the hardware plus a normal stay.

This creates two financial responses:

• Price standardization. Hospitals negotiate hard and try to steer surgeons toward a preferred vendor to cut per-unit implant cost.
• Physician preference cards. Reducing unnecessary variation in what each surgeon opens in the OR. If Dr. X routinely opens $600 of supplies that never get used, that waste comes straight out of margin.

The finance takeaway: on high-supply DRGs, the margin lives or dies on supply cost, not LOS.

Which service lines subsidize which

Once you build cost-per-case models across a hospital, a pattern appears: some service lines run consistently positive, others consistently negative.

Commonly, procedural and surgical lines (cardiology, orthopedics, certain surgeries) tend to generate positive margins under commercial payers. Meanwhile, service lines heavy in Medicaid, uninsured, or medically complex patients (behavioral health, some general medicine) often run at a loss or near breakeven.

The profitable lines effectively subsidize the unprofitable ones. This is not an accounting trick. It is how most full-service hospitals stay open while providing services that lose money but the community needs.

This is also why payer mix matters so much. The same DRG can be profitable for a commercially insured patient and unprofitable for a Medicaid patient, because Medicaid often pays below the DRG-equivalent rate. A hospital with a heavy Medicaid population faces structurally thinner margins on identical clinical work.

Using the model to manage the hospital

A good cost-per-case model is not a one-time exercise. Finance and operations teams use it to:

Target outlier cases. Flag cases where cost exceeded payment and ask why. Was it LOS? A costly implant? A complication? Patterns point to fixable process problems.

Support service line decisions. Should the hospital expand the profitable ortho program? Can it afford to keep a money-losing but essential service? The model quantifies the tradeoff instead of guessing.

Improve documentation. Sometimes a case loses money on paper because the patient's true complexity was not fully documented, so they were assigned a lower-weight DRG than their care justified. Accurate clinical documentation (capturing complications and comorbidities) ensures the case lands in the correct DRG. This is legitimate accuracy, not gaming. It matters because a more complex documented case maps to a higher-weight DRG and a payment that reflects the real resources used.

Benchmark against peers. Comparing your LOS and cost per case for a given DRG against national averages reveals whether you are efficient or bleeding.

The mindset shift

Under fee-for-service billing, more tests and more days meant more revenue. Under DRG payment, more days and more supplies mean more cost against a fixed payment. The financial incentive flips completely. Every clinical decision becomes a margin decision, and the finance team's job is to make that visible without compromising care.

Key Takeaways

• DRG payment is fixed per case, so profitability depends entirely on controlling cost per case. The payment does not change if the patient stays longer or needs more supplies.

• Length of stay is usually the biggest controllable lever. One avoidable day can flip a profitable case into a losing one, but discharging too early risks readmission penalties.

• On high-supply lines like orthopedics and cardiology, implant and device costs decide the margin, which is why hospitals push supply standardization and reduce OR waste.

• Profitable service lines subsidize unprofitable but essential ones, and payer mix (especially Medicaid share) structurally shapes whether identical clinical work earns or loses money.

• A cost-per-case model turns clinical operations into visible financial decisions, guiding outlier reviews, service line strategy, and accurate documentation.